Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis

References

• Brown WR, Tayal S. Microscopic colitis. A review. J Dig Dis 2013;14:277–81.
   PubMed Web of Science ®Google Scholar
• Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011;140:1155–65.
   PubMed Web of Science ®Google Scholar
• Kao KT, Pedraza BA, McClune AC, Rios DA, Mao YQ, Zuch RH, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol 2009;15:3122–7.
   PubMed Web of Science ®Google Scholar
• Fernandez-Banares F, Esteve M, Espinos JC, Rosinach M, Forné M, Salas A, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007;102:324–30.
   PubMed Web of Science ®Google Scholar
• Fine KD, Do K, Schulte K, Ogunji F, Guerra R, Osowski L, et al. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 2000;95:1974–82.
   PubMed Web of Science ®Google Scholar
• Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 1992;33:683–6.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A, Genta RM. Lymphocytic and collagenous colitis: epidemiologic differences and similarities. Dig Dis Sci 2013;58:2970–5.
   Google Scholar
• Baert F, Schmit A, D’Haens G, Dedeurwaerdere F, Louis E, Cabooter M, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002;122:20–5.
   PubMed Web of Science ®Google Scholar
• Bonderup OK, Hansen JB, Birket-Smith L, Vestergaard V, Teglbjaerg PS, Fallingborg J. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003;52:248–51.
   PubMed Web of Science ®Google Scholar
• Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg JF. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 2009;58:68–72.
   PubMed Web of Science ®Google Scholar
• Madisch A, Heymer P, Voss C, Wigginghaus B, Bästlein E, Bayerdörffer E, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005;20:312–16.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Heymer P, Bethke B, Bästlein E, Meier E, Bartram HP, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002;123:978–84.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008;135:1510–16.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Madisch A, Voss C, Morgner A, Heymer P, Kuhlisch E, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005;22:1115–19.
   PubMed Web of Science ®Google Scholar
• Tromm A, Griga T, Mollmann HW, May B, Muller KM, Fisseler-Eckhoff A. Budesonide for the treatment of collagenous colitis: first results of a pilot trial. Am J Gastroenterol 1999;94:1871–5.
   PubMed Web of Science ®Google Scholar
• Munck LK, Kjeldsen J, Philipsen E, Fischer Hansen B. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol 2003;38:606–10.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146:1222–30; e1221-1222.
   PubMed Web of Science ®Google Scholar
• Fine KOF, Lee E, Lafon G, Tanzi M. Randomized, double-blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis. Gastroenterology 1999;116:A880.
   Web of Science ®Google Scholar
• Munch A, Aust D, Bohr J, Bonderup O, Fernández Bañares F, Hjortswang H, et al. Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohn’s Colitis 2012;6:932–45.
   Google Scholar
• Munch A, Ignatova S, Strom M. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol 2012;47:59–63.
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Lazenby AJ, Bayless TM. The new colitides, Collagenous, lymphocytic, and diversion colitis. Gastroenterol Clin North Am 1995;24:717–29.
   Google Scholar
• Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease - microscopic colitis? Aliment Pharmacol Ther 2012;36:79–90.
   PubMed Web of Science ®Google Scholar
• Munch A, Langner C. Microscopic colitis: clinical and pathologic perspectives. Clin Gastroenterol Hepatol 2015;13:228–36.
   PubMed Web of Science ®Google Scholar
• Veress B, Lofberg R, Bergman L. Microscopic colitis syndrome. Gut 1995;36:880–6.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Madisch A, Karimi D, Wonschik S, Kuhlisch E, Beckmann R, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009;136:2092–100.
   PubMed Web of Science ®Google Scholar
• Goranzon C, Kumawat AK, Hultgren-Hornqvist E, Tysk C, Eriksson S, Bohr J, et al. Immunohistochemical characterization of lymphocytes in microscopic colitis. J Crohns Colitis 2013;7:e434–42.
   Google Scholar
• Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009;104:235–41; quiz 234, 242.
   PubMed Web of Science ®Google Scholar